HNRNPL Protein
Overview
HNRNPL (Heterogeneous Nuclear Ribonucleoprotein L) is an RNA-binding protein belonging to the heterogeneous nuclear ribonucleoprotein (hnRNP) family, a group of proteins that regulate gene expression at the post-transcriptional level. The HNRNPL gene is located on chromosome 19q13.2 and encodes a 64 kDa protein consisting of 527 amino acids. HNRNPL is ubiquitously expressed across tissues, with particularly high levels in the central nervous system. The protein contains four RNA recognition motifs (RRMs) in its N-terminal region, which facilitate binding to specific RNA sequences, and a glycine-rich domain in its C-terminus that mediates protein-protein interactions. As a core component of heterogeneous nuclear ribonucleoproteins, HNRNPL functions as a molecular regulator of RNA processing, including splicing, polyadenylation, and export of mRNA transcripts.
Function/Biology
HNRNPL operates as an essential regulator of RNA metabolism with multiple interconnected functions. Its primary role involves binding to CA-rich and GU-rich sequences within nascent RNA transcripts, acting as a splicing regulator that modulates alternative splicing patterns by promoting exon skipping or inclusion depending on its localization and binding context. Through its four RRMs, HNRNPL exhibits high-affinity binding to specific RNA secondary structures, while its C-terminal glycine-rich region facilitates interactions with other hnRNPs and splicing factors such as SR proteins (serine/arginine-rich proteins) and the spliceosome machinery.
...HNRNPL Protein
Overview
HNRNPL (Heterogeneous Nuclear Ribonucleoprotein L) is an RNA-binding protein belonging to the heterogeneous nuclear ribonucleoprotein (hnRNP) family, a group of proteins that regulate gene expression at the post-transcriptional level. The HNRNPL gene is located on chromosome 19q13.2 and encodes a 64 kDa protein consisting of 527 amino acids. HNRNPL is ubiquitously expressed across tissues, with particularly high levels in the central nervous system. The protein contains four RNA recognition motifs (RRMs) in its N-terminal region, which facilitate binding to specific RNA sequences, and a glycine-rich domain in its C-terminus that mediates protein-protein interactions. As a core component of heterogeneous nuclear ribonucleoproteins, HNRNPL functions as a molecular regulator of RNA processing, including splicing, polyadenylation, and export of mRNA transcripts.
Function/Biology
HNRNPL operates as an essential regulator of RNA metabolism with multiple interconnected functions. Its primary role involves binding to CA-rich and GU-rich sequences within nascent RNA transcripts, acting as a splicing regulator that modulates alternative splicing patterns by promoting exon skipping or inclusion depending on its localization and binding context. Through its four RRMs, HNRNPL exhibits high-affinity binding to specific RNA secondary structures, while its C-terminal glycine-rich region facilitates interactions with other hnRNPs and splicing factors such as SR proteins (serine/arginine-rich proteins) and the spliceosome machinery.
Beyond splicing regulation, HNRNPL participates in mRNA export from the nucleus to the cytoplasm. Certain hnRNPs, including HNRNPL, are retained with mRNA during nuclear export and subsequently removed in the cytoplasm, suggesting roles in mRNA quality control and translation efficiency. HNRNPL also influences mRNA stability and localization, particularly through its interactions with AU-rich elements in 3' untranslated regions of specific transcripts. Additionally, HNRNPL has been implicated in the regulation of non-coding RNAs, including microRNAs and long non-coding RNAs, expanding its role beyond classical mRNA processing.
Role in Neurodegeneration
HNRNPL has emerged as a critical factor in several neurodegenerative diseases, particularly through its involvement in the pathologic processing of disease-associated proteins. In amyotrophic lateral sclerosis (ALS), HNRNPL dysfunction has been linked to aberrant splicing of ATXN2 and other RNA targets, affecting neuronal survival pathways. The protein's role in regulating TAU alternative splicing patterns is particularly relevant to Alzheimer's disease and tauopathies, as dysregulation of tau isoform ratios contributes to pathologic tau aggregation and neurodegeneration.
HNRNPL has also been identified as a genetic risk factor in some neurodegenerative conditions through genome-wide association studies. Mutations or altered expression levels of HNRNPL can disrupt the balance of neurodegeneration-associated splicing patterns, potentially exacerbating pathologic processes. In Huntington's disease, altered hnRNP activity, including HNRNPL, affects huntingtin alternative splicing and protein aggregation susceptibility.
Molecular Mechanisms
The mechanisms by which HNRNPL contributes to neurodegeneration involve several interconnected pathways. First, dysregulation of HNRNPL-mediated splicing can produce pathologic isoforms of tau, amyloid precursor protein (APP), and other disease-associated proteins that are more prone to aggregation. Second, HNRNPL dysfunction impairs the quality control mechanisms governing mRNA export, potentially leading to accumulation of aberrant transcripts and cellular stress responses.
Third, altered HNRNPL function can affect the splicing and expression of RNA metabolism genes themselves, creating cascading regulatory failures. Fourth, HNRNPL interacts with stress granule components and RNA processing bodies, cellular organelles critical for managing neuronal stress responses. Dysregulation of these interactions during proteotoxic stress may compromise neuronal survival mechanisms.
Clinical/Research Significance
HNRNPL represents both a biomarker and potential therapeutic target for neurodegenerative diseases. Altered HNRNPL expression levels have been detected in post-mortem brain tissue from Alzheimer's disease and ALS patients. Modulating HNRNPL activity or restoring its normal splicing function presents a therapeutic avenue for correcting pathologic splicing patterns characteristic of multiple neurodegenerative conditions. RNA-based therapeutics targeting HNRNPL or its downstream splicing targets are under investigation.
Related Proteins: HNRNPA1, HNRNPA2/B1, HNRNPK, HNRNPU, HNRNPM, SR proteins (SRSF1, SRSF6)
Associated Diseases: Amyotrophic Lateral Sclerosis (ALS), Alzheimer's Disease, Tauopathies, Huntington